Mifepristone Mail Distribution Remains Available Amid FDA Review Deadline Looming
A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned that its policy could soon face major legal changes as a Food and Drug Administration review deadline approaches.